You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中關村(000931.SZ):多多藥業獲得藥品生產許可證
格隆匯 12-11 15:48

格隆匯 12 月 11日丨中關村(000931.SZ)公佈,公司全資子公司北京中關村四環醫藥開發有限責任公司之控股子公司多多藥業有限公司(多多藥業)原有《藥品生產許可證》將於2020年12月31日到期,近日,多多藥業收到黑龍江省藥品監督管理局核發新的《藥品生產許可證》。

企業名稱:多多藥業有限公司;社會信用代碼:91230800716614788A;有效期至:2025年12月31日;許可證編號:黑20160005;分類碼:Ahzt;日常監督管理機構:黑龍江省藥品監督管理局;投訴舉報電話:12331;生產地址和生產範圍:伊春市南岔區東昇街2號:中藥提取及中藥材前處理車間***黑龍江省佳木斯市東風區安慶街555號:小容量注射劑(含中藥提取),片劑、膠囊劑、顆粒劑、散劑(口服)、口服液(含中藥提取),片劑、膠囊劑(均為頭孢菌素類)、原料藥(鹽酸曲馬多、曲克蘆丁、澱粉酶、胰酶)、搽劑(外用)、溶液劑(外用)、凝膠劑,第二類精神藥品(鹽酸曲馬多片、鹽酸曲馬多注射液)***

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account